Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/1998
12/10/1998CA2291623A1 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
12/10/1998CA2290775A1 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882718A1 Benzimidazole derivatives
12/09/1998EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists
12/09/1998EP0882040A1 Antagonists of gonadotropin releasing hormone
12/09/1998EP0882038A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/09/1998EP0881908A1 Use of fibroblast growth factors to stimulate bone growth
12/09/1998EP0881905A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
12/09/1998EP0719251B1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998CN1200936A Traditional Chinese medicine extract tablet and preparation method therefor
12/09/1998CN1041053C Use of medicine of imidazole-1-yl chemical compound
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5846983 Colonic delivery of nicotine to treat inflammatory bowel disease
12/08/1998US5846967 Natriuretic and anti-hypertensive compounds
12/08/1998US5846965 3-aza and 3-oxa piperidone tachykinin antagonists
12/08/1998US5846751 Test kits and methods for detecting H. pylori
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998CA2150129C Amino-substituted pyrazoles having crf antagonistic activity
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054222A1 Cyclic crf agonists
12/03/1998WO1998054221A1 Cyclic crf antagonist peptides
12/03/1998WO1998054216A1 Gene and amino acid sequences for novel transcription factor
12/03/1998WO1998054207A1 Anti-inflammatory tyrosine derivatives
12/03/1998WO1998054190A1 Novel compounds
12/03/1998WO1998054188A1 Fused dihydropyrans
12/03/1998WO1998054187A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998WO1998054182A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
12/03/1998WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
12/03/1998WO1998054180A1 Novel compounds
12/03/1998WO1998054172A1 Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
12/03/1998WO1998054171A1 Novel form of s-omeprazole
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054166A1 A new salt
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053823A1 5-HT1A AND 5-HT1Dα ANTAGONISTS
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053818A1 Sulfonamides as cell adhesion inhibitors
12/03/1998WO1998053817A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998WO1998053814A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998WO1998053803A1 Pharmaceutical formulation of omeprazole
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998CA2528646A1 Solid pharmaceutical preparation
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291856A1 Cyclic crf antagonist peptides
12/03/1998CA2291778A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998CA2291762A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998CA2291708A1 Sulfonamides as cell adhesion inhibitors
12/03/1998CA2291674A1 5-ht1a and 5-ht1d.alpha. antagonists
12/03/1998CA2291484A1 Gene and amino acid sequences for novel transcription factor
12/03/1998CA2289542A1 Fused dihydropyrans
12/03/1998CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881224A1 5-HT1A and 5-HT1D alpha antagonists
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880529A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880528A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880526A1 Heterocycle-condensed morphinoid derivatives (ii)
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880522A1 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME
12/02/1998EP0880354A1 Urogenital and intestinal compositions
12/02/1998EP0869975A4 Assay for and uses of peptide hormone receptor ligands
12/02/1998EP0750635B1 Peptides inhibiting the release of pepsine
12/02/1998CN1040982C Method for preparing pyranoquinoline and salts thereof
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844072 Antibiotic cryptdin peptides and methods of their use
12/01/1998US5843997 Excitatory amino acid receptor antagonists
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843972 Heterocyclic β-adrenergic agonists
12/01/1998US5843966 Piperidine derivatives
12/01/1998US5843964 Methods of inhibiting endometrial mitoses
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843899 Use of insulin-like growth factors I and II for inhibition of inflammatory response
12/01/1998US5843885 ICAM-1/LFA-1 short-chain peptides and method of using same
12/01/1998US5843482 Products and processes for the treatment of the alimentary canal
12/01/1998US5843479 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
12/01/1998US5843474 Method of dialysis treatment, and dialysis apparatus related thereto
12/01/1998US5843408 Semi-paste oral preparations
11/1998
11/30/1998CA2233577A1 Histidine kinase
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/26/1998WO1998053102A1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
11/26/1998WO1998053101A2 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052942A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052929A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
11/26/1998WO1998052600A1 Methods of enhancing functioning of the upper gastrointestinal tract
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998052547A1 Gastroretentive controlled release microspheres for improved drug delivery
11/26/1998WO1998052514A2 Treatment of hepatic cirrhosis
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
1 ... 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 ... 1258